Dual-Layer 5-HTP Tablet Process for Stable Release Profiles
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing tablets comprising 5-hydroxytryptophan and tryptophan fail to maintain precise release profiles after 24 months of storage, particularly in terms of 5-HTP release from the 'fast' layer and Trp or 5-HTP release from the 'retard' layer, which is crucial for effective serotonin synthesis and bioavailability without inducing gastrointestinal disorders.
Innovation Solution
A process for preparing tablets with specific layer compositions and production steps, including granulation, drying, and sieving of 'fast' and 'retard' layers, optionally incorporating an inert layer, using ingredients like microcrystalline cellulose, croscarmellose sodium, dicalcium phosphate, and polyvinyl pyrrolidone, to ensure controlled release profiles that maintain efficacy at 24 months of storage.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If tablets are prepared with fast and retard layers using conventional mixing and granulation methods, then initial release profile is achieved, but release characteristics deteriorate after 24 months of storage
Solution Approach 1:
The tablet is divided into two distinct layers: a fast-release layer containing 5-HTP and a retard-release layer containing tryptophan or 5-HTP. Each layer is granulated separately with specific binders and disintegrants to ensure independent release characteristics. This segmentation allows each layer to maintain its release profile independently during storage, resolving the contradiction between initial release performance and long-term stability.
Solution Approach 2:
Different regions of the tablet (fast layer and retard layer) are formulated with locally optimized compositions. The fast layer uses specific binders and disintegrants for rapid release, while the retard layer uses different formulations for sustained release. This local quality approach ensures that each region maintains its specific release characteristics over 24 months of storage.
2Quantity of substance
If 5-HTP is administered in high concentrations to ensure serotonin synthesis, then therapeutic effect is improved, but gastrointestinal disorders are induced
Solution Approach 1:
The tablet delivers 5-HTP in a periodic manner through two distinct release phases: an initial fast-release phase providing therapeutic concentration, followed by a retard-release phase maintaining sustained levels. This periodic delivery prevents the continuous high concentration that causes gastrointestinal disorders while ensuring adequate therapeutic effect throughout the day.
Solution Approach 2:
The 5-HTP is segmented into two release compartments: the fast layer provides an initial therapeutic dose, while the retard layer provides sustained lower doses over time. This segmentation allows the body to process 5-HTP in manageable pulses rather than continuous high concentration, reducing gastrointestinal side effects while maintaining therapeutic efficacy.
3Speed
If tryptophan is administered rapidly to ensure bioavailability, then absorption is improved, but bioavailability decreases due to metabolic conversion
Solution Approach 1:
Tryptophan is administered in a periodic fashion through the retard layer, providing sustained release over several hours. This periodic administration allows the body to process tryptophan more efficiently, preventing rapid metabolic conversion to 5-HTP while maintaining adequate bioavailability throughout the dosing period.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The tablets exhibit over 90% release of 5-HTP from the 'fast' layer within 5 minutes and 50-70% release of Trp or 5-HTP from the 'retard' layer within 4 hours, with over 80% release within 8 hours at 24 months of storage, meeting the required specifications and ensuring effective serotonin synthesis while minimizing gastrointestinal side effects.
Implementation Method 1
granulating a mixture of the following ingredients: a first portion of microcrystalline cellulose, a first portion of croscarmellose sodium, 5-hydroxytryptophan (5-HTP), hydroxypropyl methylcellulose and a colorant, with a granulating solution comprising deionized water and polyvinyl pyrrolidone
Implementation Method 2
drying the sized granulate in a vacuum oven at 45°C to a granulate moisture content of less than 1%
Implementation Method 3
adding, to the sieved granulate, the remaining portion of croscarmellose sodium, magnesium stearate, dicalcium phosphate and polyvinyl polypyrrolidone
Data Source
AI summary
The invention concerns a process for preparing a tablet comprising at least two layers, wherein one layer is "fast" release and comprises 5-hydroxytryptophan and the other layer is "retard" release and comprises 5-hydroxytryptophan or tryptophan. The tablet obtained according to the process of the invention, at 24 months of storage, exhibits a release of more than 90% of 5-HTP from the "fast" layer within 5 minutes of administration, of about 50-70% of Trp or 5-HTP from the "retard" layer within 4 hours and of more than 80% of Trp or 5-HTP from the "retard" layer within 8 hours.